Clinical efficacy of invimestrocel for acute respiratory distress syndrome caused by pneumonia: Comparison with historical data using propensity score analysis
The addition of invimestrocel to the standard treatment for pneumonia-induced ARDS may result in early withdrawal from the ventilator and lower mortality. However, further randomized, blinded, and placebo-controlled studies without or addressing multiplicity are required to confirm these findings.
Authors
- Takeshi Johkoh (ORCID: https://orcid.org/0000-0003-1237-2349)
- Kazuya Ichikado (ORCID: https://orcid.org/0000-0002-4840-2450)
- Hideaki Imanaka
- Yasuhiro Kondoh (ORCID: https://orcid.org/0000-0001-7456-5459)
- Kiminori Fujimoto (ORCID: https://orcid.org/0000-0001-8681-7588)
- Hidenori Ichiyasu (ORCID: https://orcid.org/0000-0003-1773-8485)
- Masanori Sawada
- Sadatomo Tasaka (ORCID: https://orcid.org/0000-0003-4861-4143)
- Satoru Hashimoto (ORCID: https://orcid.org/0000-0002-6726-9966)
- Toru Kotani (ORCID: https://orcid.org/0000-0001-9504-0061)
- Kodai Kawamura (ORCID: https://orcid.org/0000-0002-6981-0648)
- Takuro Sakagami (ORCID: https://orcid.org/0000-0002-9057-1127)
- Shin Nunomiya
- Tomotaka Kawayama
Institutions
- Kurume University (JP)
- SHOWA Medical University (JP)
- Hirosaki University (JP)
- Kyoto Prefectural University of Medicine (JP)
- Saiseikai Kumamoto Hospital (JP)
- Kansai Rosai Hospital (JP)
- Social Welfare Organization Saiseikai Imperial Gift Foundation (JP)
- Naval Hospital Yokosuka Japan (JP)
- Takarazuka City Hospital (JP)
- Tosei General Hospital (JP)
- Kumamoto University (JP)
Publication Details
- Journal
- Regenerative Therapy
- Published
- 2025-03-08
- DOI
- https://doi.org/10.1016/j.reth.2025.02.018
- Primary Topic
- Respiratory Support and Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00